News

CarnoSyn Brands Partners with B&D for Supplement Distribution

CarnoSyn Brands Partners with B&D for Supplement Distribution

CarnoSyn Brands Forms Strategic Partnership with B&D Nutritional Ingredients

CarnoSyn Brands, along with its parent company Natural Alternatives International, Inc. (NASDAQ: NAII), is thrilled to unveil a new partnership with B&D Nutritional Ingredients, Inc. This collaboration marks a significant step forward in enhancing product availability in the dietary supplement landscape. B&D Nutritional Ingredients has established itself as a key player in the distribution of raw materials for dietary supplements since its inception in 1993.

Introduction of TriBsyn™ into the Market

The distribution agreement enables B&D to introduce TriBsyn™, a cutting-edge carnosine booster, to various segments such as nutritional dietary supplements, functional foods, and beverages in the U.S. market. Carnosine is a naturally occurring molecular combination formed from beta-alanine and histidine, renowned for its potent antioxidant properties. It offers a spectrum of health benefits, from improving muscle and brain function to promoting heart health and enhancing overall bodily systems.

Innovative Features of TriBsyn™

What sets TriBsyn™ apart is its patent-pending formula, which utilizes advanced technology to enhance the bioavailability and absorption of beta-alanine. Notably, it aims to mitigate the tingling sensation often experienced with traditional beta-alanine dosages, making it more appealing to a broader audience. This innovative ingredient specifically targets diverse demographics, including older adults, vegetarians, and vegans, who are looking to elevate their carnosine levels effectively.

Remarks from Company Leaders

Mark LeDoux, CEO and Chairman of the Board at NAI, expressed enthusiasm about this partnership, highlighting the benefits of collaborating with an established distributor like B&D. His confidence in B&D’s customer commitment underscores the potential for this agreement to enhance the visibility and growth prospects of TriBsyn™.

Expertise of B&D Nutritional Ingredients

B&D Nutritional Ingredients stands out for its extensive expertise across multiple industries, including dietary supplements, functional foods, personal care, and pet health. Their distribution capabilities are enhanced by their well-stocked warehouse and understanding of market needs, making them an ideal partner for advancing TriBsyn™ to a broader audience.

Strategic Growth in the Market

Bill Van Dyke, President of B&D, shared his excitement about promoting TriBsyn™, noting that this ingredient seamlessly complements their existing product offerings. The collaboration aims to position TriBsyn™ as a go-to ingredient in formulations targeting anti-aging, cognitive improvement, and physical performance.

About B&D Nutritional Ingredients

Since its founding in 1993, B&D Nutritional Ingredients has emerged as a national leader in the distribution and marketing of premium dietary ingredients. Their commitment to high-quality products has allowed them to build strong relationships within various health-focused industries. B&D actively participates in several professional organizations that represent the interests of dietary supplement and personal care sectors.

About CarnoSyn® Brands

CarnoSyn® Brands: Known for its clinically studied and patented ingredients, CarnoSyn® Brands provides high-quality products exclusively through Natural Alternatives International, Inc. Their lineup includes CarnoSyn® instant release beta-alanine, SR CarnoSyn® sustained release beta-alanine, and the innovative TriBsyn™. The company has made significant progress by obtaining NDI status and GRAS affirmation for its products, paving the way for further advancements in the dietary supplement sector.

About Natural Alternatives International, Inc.

Headquartered in Carlsbad, California, NAI is recognized for its expertise in formulating, manufacturing, and marketing nutritional supplements. They pride themselves on their comprehensive partnership approach, offering a wide range of innovative products and services tailored to client needs, including product testing, formulation, and regulatory assistance.

Frequently Asked Questions

What is TriBsyn™?

TriBsyn™ is a patent-pending carnosine booster developed to enhance beta-alanine absorption and minimize the sensation of paresthesia associated with traditional beta-alanine consumption.

Who are the partners involved in the distribution agreement?

The partnership involves CarnoSyn Brands, its parent company Natural Alternatives International, Inc. (NASDAQ: NAII), and B&D Nutritional Ingredients, Inc.

What health benefits does carnosine provide?

Carnosine is known for its antioxidant properties and supports health benefits for muscle, cognitive function, heart health, and overall systemic wellness.

When did the partnership take effect?

The distribution partnership between CarnoSyn Brands and B&D Nutritional Ingredients became effective on October 1, 2024.

What industries does B&D serve?

B&D serves various industries including dietary supplements, functional foods, personal care, pet health, and craft breweries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Albion Enterprise VCT PLC Boosts Equity with New Share Allotment

Updated Category News Views 202

Albion Enterprise VCT PLC Enhances Its Equity Portfolio Albion Enterprise VCT PLC (LSE: AAEV) has recently made a significant move to bolster its equity by issuing new shares. This decision aligns with the company’s commitment to expanding its capital while providing opportunities for shareholders through its Dividend Reinvestment Scheme. Details of the New Share...

Continue Reading
Capsida Biotherapeutics and AbbVie's Collaboration Milestones

Updated Category News Views 215

Capsida's Recent Advances in Genetic Medicine Capsida Biotherapeutics has made a remarkable stride by partnering with AbbVie to combat neurodegenerative diseases, a step that marks a significant achievement in the realm of genetic medicine. The collaboration has evolved, leading to AbbVie exercising its option on the first neurodegenerative disease program, which...

Continue Reading
AB Amber Grid Sees Decrease in Revenue Yet Growth in Profitability

Updated Category News Views 239

AB Amber Grid's 2024 Operating Results Overview AB Amber Grid has published its unaudited financial results for the year 2024, reflecting the company’s performance in accordance with the International Financial Reporting Standards. With a focus on strategic growth, the company demonstrated robust management despite challenges in the market. Financial Performance...

Continue Reading
Linkage Global Secures $1 Million in Private Placement Financing

Updated Category News Views 245

Linkage Global Inc. Closes $1 Million Private Placement Financing Linkage Global Inc (NASDAQ: LGCB), a leading cross-border e-commerce service provider based in Japan, has successfully completed a private placement financing that raised $1 million. This announcement marks a significant milestone for the company as it continues to enhance its financial foundation. Details...

Continue Reading
Amedisys and UnitedHealth Merger Update: What to Expect

Updated Category News Views 781

Understanding the Amedisys and UnitedHealth Merger Situation Amedisys Inc (NASDAQ: AMED) has seen its shares rise as the company announces an extension to its merger deadline with UnitedHealth Group Incorporated (NYSE: UNH). This unexpected turn of events has grabbed the attention of investors and industry watchers alike. What Is the Merger About? The proposed merger...

Continue Reading